Section 16-13-28. Schedule IV

   (a) The controlled substances listed in this Code section are included in Schedule IV. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specified chemical designation, included as having a stimulant or depressant effect on the central nervous system or a hallucinogenic effect:

   (1) Alprazolam;

   (1.5) Armodafinil;

   (2) Barbital;

   (2.1) Bromazepam;

   (2.15) Butorphanol;

   (2.2) Camazepam;

   (2.25) Carisoprodol;

   (2.3) Cathine;

   (3) Chloral betaine;

   (4) Chloral hydrate;

   (5) Chlordiazepoxide, but not including librax (chlordiazepoxide hydrochloride and clidinium bromide) or menrium (chlordiazepoxide and water soluble esterified estrogens);

   (5.1) Clobazam;

   (6) Clonazepam;

   (7) Clorazepate;

   (7.1) Clotiazepam;

   (7.2) Cloxazolam;

   (7.3) Delorazepam;

   (8) Desmethyldiazepam;

   (8.5) Dexfenfluramine;

   (9) Reserved;

   (10) Diazepam;

   (11) Diethylpropion;

   (11.05) Difenoxin;

   (11.1) Estazolam;

   (12) Ethchlorvynol;

   (13) Ethinamate;

   (13.1) Ethyl loflazepate;

   (13.2) Fencamfamin;

   (14) Fenfluramine;

   (14.1) Flunitrazepam;

   (14.2) Fenproporex;

   (15) Flurazepam;

   (15.3) Fospropofol;

   (16) Halazepam;

   (16.1) Haloxazolam;

   (16.15) Indiplon;

   (16.2) Ketazolam;

   (16.3) Lometazepam;

   (16.4) Loprazolam;

   (17) Lorazepam;

   (18) Mazindol;

   (19) Mebutamate;

   (19.1) Medazepam;

   (19.2) Mefenorex;

   (20) Meprobamate;

   (21) Methohexital;

   (22) Methylphenobarbital;

   (22.1) Midazolam;

   (22.15) Modafinil;

   (22.2) Nimetazepam;

   (22.3) Nitrazepam;

   (22.4) Nordiazepam;

   (23) Oxazepam;

   (23.1) Oxazolam;

   (24) Paraldehyde;

   (25) Pemoline;

   (26) Pentazocine;

   (27) Petrichloral;

   (28) Phenobarbital;

   (29) Phentermine;

   (29.1) Pipradrol;

   (30) Prazepam;

   (30.03) Propofol;

   (30.05) Propoxyphene (including all salts and optical isomers);

   (30.1) Quazepam;

   (30.2) Sibutramine;

   (30.3) SPA (-)-1-dimethylamino-1, 2-diphenylethane;

   (31) Temazepam;

   (32) Triazolam;

   (32.5) Zaleplon;

   (33) Zolpidem;

   (34) Zopiclone.

(b) The State Board of Pharmacy may except by rule any compound, mixture, or preparation containing any depressant, stimulant, or hallucinogenic substance listed in subsection (a) of this Code section from the application of all or any part of this article if the compound, mixture, or preparation contains one or more active, medicinal ingredients not having a depressant or stimulant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a depressant or stimulant effect on the central nervous system.

Code 1933, § 79A-809, enacted by Ga. L. 1974, p. 221, § 1; Ga. L. 1977, p. 1287, § 1; Ga. L. 1979, p. 859, § 8; Ga. L. 1980, p. 1746, § 7; Ga. L. 1981, p. 557, § 4; Ga. L. 1982, p. 3, § 16; Ga. L. 1982, p. 2403, §§ 14, 19; Ga. L. 1984, p. 22, § 16; Ga. L. 1985, p. 1219, § 4; Ga. L. 1986, p. 10, § 16; Ga. L. 1986, p. 1555, § 4; Ga. L. 1987, p. 261, § 5; Ga. L. 1989, p. 233, § 4; Ga. L. 1990, p. 8, § 16; Ga. L. 1993, p. 590, § 2; Ga. L. 1994, p. 169, § 5; Ga. L. 1996, p. 1023, § 1; Ga. L. 1997, p. 1311, § 3; Ga. L. 1998, p. 778, § 2; Ga. L. 1999, p. 643, § 1; Ga. L. 2000, p. 1317, § 3; Ga. L. 2003, p. 349, § 4; Ga. L. 2006, p. 219, § 2/HB 1054; Ga. L. 2007, p. 47, § 16/SB 103; Ga. L. 2008, p. 169, § 5/HB 1090; Ga. L. 2009, p. 126, §§ 3, 4/HB 368; Ga. L. 2010, p. 860, § 3/SB 353; Ga. L. 2011, p. 656, § 5/SB 93.